138 related articles for article (PubMed ID: 37567393)
1. Transplantation after CD45-ADC corrects Rag1 immunodeficiency in congenic and haploidentical settings.
Pala F; Corsino C; Calzoni E; Villa A; Pittaluga S; Palchaudhuri R; Bosticardo M; Notarangelo LD
J Allergy Clin Immunol; 2024 Jan; 153(1):341-348.e3. PubMed ID: 37567393
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of anti-CD45-saporin as conditioning agent for RAG deficiency.
Castiello MC; Bosticardo M; Sacchetti N; Calzoni E; Fontana E; Yamazaki Y; Draghici E; Corsino C; Bortolomai I; Sereni L; Yu HH; Uva P; Palchaudhuri R; Scadden DT; Villa A; Notarangelo LD
J Allergy Clin Immunol; 2021 Jan; 147(1):309-320.e6. PubMed ID: 32387109
[TBL] [Abstract][Full Text] [Related]
3. A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice.
Saha A; Hyzy S; Lamothe T; Hammond K; Clark N; Lanieri L; Bhattarai P; Palchaudhuri R; Gillard GO; Proctor J; Riddle MJ; Panoskaltsis-Mortari A; MacMillan ML; Wagner JE; Kiem HP; Olson LM; Blazar BR
Blood; 2022 Mar; 139(11):1743-1759. PubMed ID: 34986233
[TBL] [Abstract][Full Text] [Related]
4. Stable multilineage chimerism without graft versus host disease following nonmyeloablative haploidentical hematopoietic cell transplantation.
Cina RA; Wikiel KJ; Lee PW; Cameron AM; Hettiarachy S; Rowland H; Goodrich J; Colby C; Spitzer TR; Neville DM; Huang CA
Transplantation; 2006 Jun; 81(12):1677-85. PubMed ID: 16794534
[TBL] [Abstract][Full Text] [Related]
5. Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying
Castiello MC; Di Verniere M; Draghici E; Fontana E; Penna S; Sereni L; Zecchillo A; Minuta D; Uva P; Zahn M; Gil-Farina I; Annoni A; Iaia S; Ott de Bruin LM; Notarangelo LD; Pike-Overzet K; Staal FJT; Villa A; Capo V
Front Immunol; 2023; 14():1268620. PubMed ID: 38022635
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment.
Orozco JJ; Kenoyer A; Balkin ER; Gooley TA; Hamlin DK; Wilbur DS; Hylarides MD; Frost SH; Mawad R; O'Donnell P; Sandmaier BM; Fuchs EJ; Luznik L; Green DJ; Gopal AK; Press OW; Pagel JM
Blood; 2016 Jan; 127(3):352-9. PubMed ID: 26576864
[TBL] [Abstract][Full Text] [Related]
7. Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Burroughs LM; Torgerson TR; Storb R; Carpenter PA; Rawlings DJ; Sanders J; Scharenberg AM; Skoda-Smith S; Englund J; Ochs HD; Woolfrey AE
J Allergy Clin Immunol; 2010 Nov; 126(5):1000-5. PubMed ID: 20643476
[TBL] [Abstract][Full Text] [Related]
8. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
Lanfranchi A; Verardi R; Tettoni K; Neva A; Mazzolari E; Pennacchio M; Pasic S; Ugazio AG; Albertini A; Porta F
Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
10. Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study.
Straathof KC; Rao K; Eyrich M; Hale G; Bird P; Berrie E; Brown L; Adams S; Schlegel PG; Goulden N; Gaspar HB; Gennery AR; Landais P; Davies EG; Brenner MK; Veys PA; Amrolia PJ
Lancet; 2009 Sep; 374(9693):912-20. PubMed ID: 19729196
[TBL] [Abstract][Full Text] [Related]
11. A Depleting Anti-CD45 Monoclonal Antibody as Isolated Conditioning for Bone Marrow Transplantation in the Rat.
Jäger MD; Vondran FW; Ramackers W; Röseler T; Schlitt HJ; Bektas H; Klempnauer J; Timrott K
PLoS One; 2016; 11(5):e0154682. PubMed ID: 27139494
[TBL] [Abstract][Full Text] [Related]
12. Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
Balashov D; Shcherbina A; Maschan M; Trakhtman P; Skvortsova Y; Shelikhova L; Laberko A; Livshits A; Novichkova G; Maschan A
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1955-62. PubMed ID: 26187864
[TBL] [Abstract][Full Text] [Related]
13. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
14. [Haploidentical allogenetic hematopoietic stem cell transplantation for X-linked adrenoleukodystrophy].
Chen Y; Zhang XH; Xu LP; Liu KY; Qin J; Yang YL; Huang XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 51(3):409-413. PubMed ID: 31209410
[TBL] [Abstract][Full Text] [Related]
15. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience.
Knutsen AP; Wall DA
J Clin Immunol; 2000 Nov; 20(6):466-76. PubMed ID: 11202237
[TBL] [Abstract][Full Text] [Related]
16. Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate conditioned Fanconi anemia mice.
Saha A; Palchaudhuri R; Lanieri L; Hyzy S; Riddle MJ; Panthera J; Eide C; Tolar J; Panoskaltsis-Mortari A; Gorfinkel L; Tkachev V; Gerdemann U; Alvarez-Calderon F; Palato ER; MacMillan ML; Wagner JE; Kean LS; Osborn M; Kiem HP; Scadden DT; Olson LM; Blazar BR
Blood; 2024 Mar; ():. PubMed ID: 38447038
[TBL] [Abstract][Full Text] [Related]
17. CD45 congenic bone marrow transplantation: evidence for T cell-mediated immunity.
Xu H; Exner BG; Chilton PM; Schanie C; Ildstad ST
Stem Cells; 2004; 22(6):1039-48. PubMed ID: 15536194
[TBL] [Abstract][Full Text] [Related]
18. [Earlier hematopoietic reconstitution by mouse cord blood transplantation combined with bone marrow c-kit(+) hematopoietic progenitor cells].
Yuan YH; Li J; Yu YH; Shi J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):416-21. PubMed ID: 21518499
[TBL] [Abstract][Full Text] [Related]
19. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency.
Grossman J; Cuellar-Rodriguez J; Gea-Banacloche J; Zerbe C; Calvo K; Hughes T; Hakim F; Cole K; Parta M; Freeman A; Holland SM; Hickstein DD
Biol Blood Marrow Transplant; 2014 Dec; 20(12):1940-8. PubMed ID: 25111582
[TBL] [Abstract][Full Text] [Related]
20. Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK Experience.
Slatter MA; Rao K; Abd Hamid IJ; Nademi Z; Chiesa R; Elfeky R; Pearce MS; Amrolia P; Worth A; Flood T; Abinun M; Hambleton S; Qasim W; Gaspar HB; Cant AJ; Gennery AR; Veys P
Biol Blood Marrow Transplant; 2018 Mar; 24(3):529-536. PubMed ID: 29155317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
